Niall O'Donnell, Director at Reneo Pharmaceuticals, Inc. (RPHM), bought 1,234,600 shares at $15.00 ($3.0M) on 2021-04-13, disclosed to the SEC on 2021-04-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,034,600 | $0 | 0.0% |
| 2 | $15.00 | 200,000 | $3.0M | 100.0% |
| Total | $2.43 avg | 1,234,600 | $3.0M | 100% |
| Filing → |
| MIRM | SELL | 2022-11-15 | $11.9M | — | Filing → |
| SPRB | BUY | 2020-10-16 | $3.8M | — | Filing → |
| MIRM | BUY | 2019-07-24 | $4.5M | — | Filing → |